The integrity of the disulfide bond in a cyclic somatostatin analog during 99mTc complexation reactions

Nuclear Medicine and Biology

Volumn 26, Issue 8, 1999, Pages 883-890

  Uehara, Tomoya ^a   Arano, Yasushi ^a   Ono, Masahiro ^a   Fujioka, Yasushi ^a   Ogawa, Kazuma ^a   Namba, Shinji ^a   Nakayama, Morio ^b   Koizumi, Mitsuru ^c   Fujii, Nobutaka ^d   Horiuchi, Kazuko ^a   Yokoyama, Akira ^a   Saji, Hideo ^a  

^a Grad Sch Pharmaceutical Sci   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

99mTc; Cyclic peptide; Disulfide bond; Reduction; Stannous ions

Indexed keywords

ASCORBIC ACID; IODINE 125; SOMATOSTATIN DERIVATIVE; TECHNETIUM 99M; TIN DERIVATIVE;

ARTICLE; CHELATION; CHEMICAL REACTION; CHEMICAL STRUCTURE; COMPLEX FORMATION; DISULFIDE BOND; ISOTOPE LABELING; MOLECULAR STABILITY;

ASCORBIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISULFIDES; DITHIONITE; IODINE RADIOISOTOPES; ISOTOPE LABELING; RADIOPHARMACEUTICALS; REDUCING AGENTS; SOMATOSTATIN; TECHNETIUM; TIN;

EID: 0033394542     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00066-9     Document Type: Article

References (25)

1. 1-octreotide in vivo. Bioconjugate Chem. 9:1998;662-670.
2. 1-octreotide synthesis . Bioconjugate Chem. 8:1997;442-446.
3. Arano Y., Wakisaka K., Mukai T., Uezono T., Motonari H., Akizawa H., Kairiyama C., Ohmomo Y., Tanaka C., Ishiyama M., et al. Stability of a metabolizable ester bond in radioimmunoconjugates. Nucl. Med. Biol. 23:1996;129-136.
4. Arpicco S., Dosio F., Brusa P., Crosasso P., Cattel L. New coupling reagents for the preparation of disulfide cross-linking conjugates with increased stability. Bioconjugate Chem. 8:1997;327-337.
5. Bakker W.H., Breeman W.A.P., Pluijm M.E.V.D., Jong M.D., Visser T.J. Iodine-131 labelled octreotide Not an option for somatostatin receptor therapy . Eur. J. Nucl. Med. 23:1996;775-781.
6. Bakker W.H., Krenning E.P., Breeman W.A., Koper J.W., Kooji P.P., Reubi J.-C., Klijin J.G., Visser T.J., Docter R., Lamberts S.W. Receptor scintigraphy with a radioiodinated somatostatin analogue Radiolabeling, purification, biologic activity, and in vivo application in animals . J. Nucl. Med. 31:1990;1501-1509.
7. 3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Int. J. Cancer. 75:1998;406-411.
8. 111In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. Cancer-Res. 58:1998;437-441.
9. Fischman A.J., Babich J.W., Strauss H.W. A ticket to ride - Peptide radiopharmaceuticals. J. Nucl. Med. 34:1993;2253-2263.
10. Greenfield L., Bloch W., Moreland M. Thiol-containing cross-linking agent with enhanced steric hindrance. Bioconjugate Chem. 1:1990;400-410.
11. Kaiser E., Colescott R.L., Bossinger C.D., Cook P.I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34:1970;595-598.
12. 67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugate in mice. Cancer Res. 48:1988;1189-1194.
13. 111In-DTPA-octreotide . Peptide Res. 9:1996;144-150.
14. Maina T., Stolz B., Albert R., Bruns C., Koch P., Macke H. Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99m. Eur. J. Nucl. Med. 21:1994;437-444.
15. Pearson D.A., Lister-James J., McBride W.J., Wilson D.M., Martel L.J., Civitello E.R., Taylor J.E., Moyer B.R., Dean R.T. Somatostatin receptor-binding peptides labeled with technetium-99m Chemistry and initial biological studies . J. Med. Chem. 39:1996;1361-1371.
16. Schally A.V. Oncological applications of somatostatin analogues. Cancer Res. 48:1988;6977-6985.
17. Thakur M.L. Radiolabeled peptides Now and future . Nucl. Med. Commun. 6:1995;724-732.
18. Thakur M.L., Defulvio J., Richard M.D., Park C.H. Technetium-99m labeled monoclonal antibodies Evaluation of reducing agents . Nucl. Med. Biol. 18:1991;227-234.
19. Thakur M.L., Kolan H.R., Rifat S., Li J., Rux A., John E., Halmos G., Schally A.V. Vapreotide labeled with Tc-99m for imaging tumors Preparation and preliminary evaluation . Int. J. Oncol. 9:1996;445-451.
20. Thannhauser T.W., Konishi Y., Scheraga H.A. Sensitive quantitative analysis of disulfide bonds in polypeptides and proteins. Anal. Biochem. 138:1984;161-188.
21. Thorpe P.E., Wallace P.M., Knowles P.P., Relf M.G., Brown A.N.F., Watson G.J., Knyba R.E., Wawrzyncraz E.J., Blakey D.C. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Cancer Res. 47:1987;5924-5931.
22. 99mTc-PnAO); a potential brain radiopharmaceutical. Eur. J. Nucl. Med. 9:1984;511-516.
23. 99mTc radiopharmaceuticals. Nucl. Med. Biol. 25:1998;295-303.
24. 188Re-RC-160 somatostatin analog: A peptide for local/regional radiotherapy. Appl. Radiat. Isot. 48, 305-309.
25. Zamora P.O., Rhodes B.A. Imidazoles as well as thiolates in proteins bind technetium-99m. Bioconjugate Chem. 3:1992;493-498.